Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Previous years tags : Alliances save search
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
EVO | News | $7.15 -1.24% -0.7% 27K
|
Manufacturing
|
| O: 0.42%
H: 0.0%
C: 0.0%
partnership fibrosis
InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
SLP | $44.41 -0.65% -0.47% 98K
|
Technology Services
|
| O: 0.86%
H: 0.68%
C: -2.3%
drug solutions for plus
CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
Published: 2024-04-16 (Crawled : 13:00) - biospace.com/
CVAC | News | $2.44 -5.06% -5.33% 120
|
Health Technology
|
| O: -0.38%
H: 3.41%
C: 0.95%
cancer collaboration
BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients
Published: 2024-04-16 (Crawled : 13:00) - biospace.com/
NIPNF | $68.91 -7.25% -52.94% 0
|
Technology Services
| Email alert
Add to watchlist
lung cancer immunotherapy for collaboration saga response biomarkers
U.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy
Published: 2024-04-05 (Crawled : 14:00) - biospace.com/
TSVT | $4.64 -8.3% -8.82% 620K
|
|
| O: 7.98%
H: 9.06%
C: -9.06%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -0.41%
H: 0.51%
C: 0.25%
fda for therapy
Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate
Published: 2024-04-04 (Crawled : 00:00) - biospace.com/
TEVA | $12.78 -3.03% -1.8% 8.4M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
candidate biosimilar global for teva agreement
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
DGX | $125.91 -0.84% 0.0% 870K
|
Health Services
|
| O: -0.13%
H: 0.0%
C: -1.72%
test genetic diagnostics
Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
NRIX 2 d | $14.44 2.56% 2.43% 1.5M
|
Health Technology
|
| O: -1.59%
H: 6.37%
C: 4.57%
sciences collaboration extension therapeutics
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
Published: 2024-04-01 (Crawled : 18:00) - biospace.com/
LH M | $199.45 -0.26% 0.0% 770K
|
Health Services
|
| O: -0.54%
H: 0.23%
C: -0.43%
cell collaboration therapy
Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
BX | $120.32 -2.33% -1.22% 5.2M
|
Finance
|
| O: 1.27%
H: 1.14%
C: 1.07%
MRNA S | $102.0 -1.39% -1.4% 1.4M
|
Health Technology
|
| O: 2.02%
H: 1.41%
C: 0.92%
life influenza sciences collaboration program
Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson's Disease
Published: 2024-03-26 (Crawled : 19:00) - biospace.com/
DNLI | $16.6 -1.31% -1.33% 830K
|
Health Technology
|
| O: 1.33%
H: 0.25%
C: -1.27%
disease parkinson's health technology biomarkers
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
Published: 2024-03-22 (Crawled : 21:00) - biospace.com/
AZZ | $75.48 -0.17% 0.0% 140K
|
Producer Manufacturing
|
| O: -1.74%
H: 0.37%
C: -3.24%
india agreement market
Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases
Published: 2024-03-21 (Crawled : 21:00) - biospace.com/
KZIA | $0.3462 0.58% 2.27% 270K
|
Health Technology
|
| O: -6.81%
H: 8.65%
C: -2.23%
rare paxalisib system therapeutics
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
Published: 2024-03-20 (Crawled : 13:00) - biospace.com/
NLSP | $0.1327 -0.23% 6.04% 97K
|
|
| O: 7.65%
H: 31.03%
C: -45.86%
agonist license global platform
Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System
Published: 2024-03-19 (Crawled : 15:00) - biospace.com/
NBIO | $0.0924 -3.25% 15.32% 450
|
|
| O: -13.87%
H: 20.93%
C: 17.8%
pharma transdermal system
Merck Bets Potential $1B on Pearl Bio’s Genomically Recoded Organisms
Published: 2024-03-12 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
merck potential
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4
Published: 2024-03-07 (Crawled : 14:30) - biospace.com/
APVO 3 d | $0.77 8.07% 6.25% 210K
|
Health Technology
|
| O: 19.53%
H: 41.18%
C: -13.73%
apv-527 alg.apv-527 positive bioscience tumor therapeutics study
Simulations Plus and the University of Bath Awarded New FDA Grant - March 5, 2024
Published: 2024-03-05 (Crawled : 14:00) - biospace.com/
SLP | $44.41 -0.65% -0.47% 98K
|
Technology Services
|
| O: 0.07%
H: 3.92%
C: 3.18%
fda grant plus
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
MASS | $5.6 0.18% 0.36% 160K
|
|
| O: 4.01%
H: 1.67%
C: -5.53%
cell therapy platform
Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203
Published: 2024-02-27 (Crawled : 14:00) - biospace.com/
AMRX | $5.36 -1.83% -1.87% 840K
|
Health Technology
|
| O: -1.89%
H: 1.75%
C: 0.0%
ipx203 biotech agreement
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
UMAC | $1.55 0.65% 12.9% 0
|
TAOP | $1.08 13.01% 11.51% 19K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.